@entity23797 and XXXX are overexpressed in @entity5 .

@entity5 @entity75 @entity189 @entity34650 @entity23797 @entity2784
UNASSIGNED: We investigated the expression of @entity23797 ( @entity23797 ) and @entity34650 ( @entity34650 ) in @entity5 . To analyze @entity23797 and @entity34650 expression, an endocervical cytobrush sample was taken for total RNA isolation. @entity34650 and @entity23797 mRNA was quantified from total RNA using quantitative reverse transcription-polymerase chain reaction. A total of 71 samples were collected and classified according to the Bethesda Classification of squamous @entity75 . @entity23797 expression was observed in 9 (12.7%) samples; of these, 5.3, 5.9, 14.8, and 37.5% in the groups that were cytology negative for intraepithelial lesion or malignancy, @entity2784 ( @entity2784 ), @entity2784 ( @entity2784 ), and @entity189 , respectively. The expression level of @entity23797 was significantly higher in the group with @entity189 as compared with the groups negative for intraepithelial lesion or malignancy, @entity2784 , and @entity2784 (P < 0.0005). @entity34650 mRNA was expressed in all samples. @entity34650 expression was significantly higher in @entity189 groups compared with @entity2784 , @entity2784 , and negative for intraepithelial lesion or malignancy groups. We found that @entity23797 and @entity34650 expressions in the @entity2784 and @entity189 groups were higher than expression in cytological normal samples. Additional studies should be conducted to examine the function of transcription factors during different stages of the transformation of cervical @entity5 cells.
